T2456 |
Tivozanib
|
475108-18-0
|
98%
|
|
Tivozanib is an orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplasti...
|
T1448L |
Dasatinib monohydrate
|
863127-77-9
|
98%
|
|
Dasatinib is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoti...
|
TQ0166 |
Tesevatinib
|
781613-23-8
|
98%
|
|
Tesevatinib is an orally available, multi-target tyrosine kinase inhibitor (IC50s: 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR, ErbB2, KDR, Flt4, and EphB4).
|
T6348 |
NVP-BHG712
|
940310-85-0
|
98%
|
|
NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition; also shows activity against c-Raf, c-Src and c...
|
T5452 |
Ehp-inhibitor-2
|
861249-77-6
|
98%
|
|
Ehp-inhibitor-2 is an Eph family tyrosine kinase inhibitor targeting Eph receptors.
|
T9650 |
AZ12672857
|
945396-55-4
|
98%
|
|
AZ12672857 is an inhibitor of EphB4 with IC50 of 1.3 nM. AZ12672857 inhibits cell proliferation of Src transfected 3T3 cells with IC50 of 2 nM and autophosphoryl...
|
TP1561 |
123C4
|
2034159-30-1
|
98%
|
|
123C4 is a novel, potent, and selective agonist of the tyrosine kinase EphA4 receptor.
|
T3476 |
JI-101
|
900573-88-8
|
98%
|
|
JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PD...
|
T5451 |
Eph inhibitor 2
|
861249-59-4
|
98%
|
|
Ehp-inhibitor-1 is an Eph family tyrosine kinase inhibitor targeting Eph receptors.
|
T4344 |
ALW-II-41-27
|
1186206-79-0
|
98%
|
|
ALW-II-41-27, an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.
|
T19487 |
NVP-BHG712 isomer
|
2245892-85-5
|
98%
|
|
NVP-BHG712 isomer shows conserved non-bonded binding to EPHA2 and EPHB4.
|
T4349 |
Sitravatinib
|
1123837-84-2
|
98%
|
|
Sitravatinib (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRα/β, PDGFR, and Axl.
|
TP1895L1 |
KYL acetate(676657-00-4 free base)
|
TP1895L1
|
98%
|
|
EphA4 receptor tyrosine kinase inhibitor (Kd = 0.8 μM); inhibits EphA4-EphrinA5 interactions (IC50 = 6.34 μM). Prevents AβO induced synaptic damage, dendritic sp...
|
T67736 |
ALW-II-49-7
|
1135219-23-6
|
98%
|
|
ALW-II-49-7 is a selective and potent inhibitor of EphB2 kinase with an EC50 value of 40 nM in cell.
|
T38511 |
AWL-II-38.3
|
1135205-94-5
|
98%
|
|
AWL-II-38.3 is a highly effective inhibitor of EphA3, a receptor for ephrin-A. It demonstrates potent kinase inhibitory activity against EphA3 and does not show ...
|